AZZALURE®

AZZALURE®

Within the wider botulinum toxin type A category, Azzalure® occupies a fairly narrow position. It is the EU and UK aesthetic brand for abobotulinumtoxinA, produced by Ipsen and marketed under Galderma, licensed as a prescription-only medicine and supplied in 125 Speywood unit vials for the treatment of glabellar lines and lateral canthal lines [2][3]. Healthcare professionals looking into how to buy Azzalure® online will find that Medical Spa Rx representatives can offer guidance on sourcing, availability, and what qualified buyers need to have in place.

What Is Azzalure®? AbobotulinumtoxinA for the EU/UK Aesthetic Market

Azzalure® is a botulinum toxin type A product built around abobotulinumtoxinA, produced by Ipsen and distributed regionally under the Galderma name [3]. Its marketing authorization covers the EU and UK aesthetic market only, which separates it from sister products sold elsewhere under different branding.

As a muscle relaxant, Azzalure® blocks the release of acetylcholine at the neuromuscular junction. Without that chemical signal reaching the muscle fibers, the targeted facial muscles cannot contract with the same force, and the wrinkles that form above them soften as a result [2]. That mechanism of action is shared across the BTX-A class, so what differentiates the brands are units, licensing, complexing proteins, and storage.

Key Specifications

• Prescription-only medicine authorized for the EU and UK aesthetic market
• Supplied as Azzalure 125U lyophilized powder, requiring reconstitution before injection
• Sold as a 2-vial pack rather than across a range of vial sizes
• Approved for moderate to severe glabellar lines and lateral canthal lines in adults under 65 [2]

Is Azzalure® Same as DYSPORT®? Clarifying the Brand Relationship

Mostly, but not entirely. Azzalure® and DYSPORT® are built on the same molecule, abobotulinumtoxinA, and come from the same manufacturer, Galderma/Ipsen [3]. What separates them is not the formula. It is where and how each one is licensed.

DYSPORT® is the globally recognized name, FDA-approved, and licensed for both aesthetic and therapeutic indications depending on the market. Azzalure® is restricted to the EU and the UK, and to aesthetic use only, with glabellar lines and lateral canthal lines as its approved indications [2]. A practitioner switching between the two for a comparable treatment needs no dose conversion, because both run on the same Speywood, or Galderma, unit.

The comparison becomes more complex when either product is measured against BOTOX®. Speywood units are not interchangeable with BOTOX® units, so the same numerical dose cannot be carried across directly. A conversion of roughly 2.5 to 3 Speywood units for every 1 BOTOX® unit is often cited, but published estimates vary and no single ratio applies universally. Practitioners need to account for the specific product, treatment area, and clinical context before converting a dose or switching a patient between Azzalure® and BOTOX®.

Regulatory Status: CE Marking and FDA Position

Azzalure® is frequently described as CE-marked, but that is not the correct regulatory framing. CE marking applies to medical devices. Botulinum toxins in the EU and UK are regulated as prescription medicinal products, authorized through marketing authorizations granted by national agencies, the EMA, or the MHRA [2].

Under that authorization, Azzalure® is approved to treat moderate to severe glabellar lines and lateral canthal lines seen at maximum smile in adult patients under 65 [2]. It is not FDA-approved. In the United States, the same abobotulinumtoxinA molecule is available under the DYSPORT® brand, which is FDA-approved.

Like every product in this class, Azzalure® is prescription-only wherever it is licensed [2]. Clinics evaluating where to order Azzalure® online, or to order Azzalure® wholesale for a clinic’s ongoing supply, generally weigh distributor credentials, documentation, and cold-chain handling ahead of price, and the prescription-only status means verification of professional credentials is part of any legitimate sourcing route.

Azzalure® 125U — Product Presentation

Azzalure® comes in one format only: a 125 Speywood unit vial of lyophilized powder, supplied as an Azzalure 125IU 2-vial pack [2]. There is no broader range of vial sizes to choose between. Clinics that buy Azzalure® products in this 2-vial format should plan reconstitution volume around the single presentation, since there is no smaller vial to draw from when a session calls for less.

The pack suits multi-area or bilateral protocols within one appointment, as both vials can be reconstituted and used within the same 24-hour window. The powder must be reconstituted before injection and is not ready to use out of the box.

Treatment Areas and Indications

The approved indications for Azzalure® are moderate to severe glabellar lines and lateral canthal lines (crow’s feet) seen at maximum smile, both in adult patients under 65 [2]. Dynamic wrinkles are often caused by repeated contraction of the underlying muscles, and Azzalure® relaxes those facial muscles to reduce the appearance of surface wrinkles [4].

Off-label, practitioners sometimes use Azzalure® for:

• Forehead wrinkles
• Subtle adjustments around the eyebrows and lips
• Neck bands
• Certain skin depressions

Severe underarm sweating is another condition treated with botulinum toxin, though within this manufacturer’s portfolio it is more typically associated with DYSPORT® in some markets. Indication approval differs by country, so confirming what Azzalure® specifically carries locally is worth doing before considering it for hyperhidrosis.

Onset, Duration, and Clinical Performance

Azzalure® typically begins to take effect within two to five days, with the full result becoming apparent after about 10 to 14 days.[1] Some practitioners feel that its onset is slightly faster than that of other botulinum toxin type A products. However, randomized controlled trials have not consistently confirmed this, so it is better regarded as a clinical observation rather than an established product advantage.

Results generally last three to four months, although some patients may retain the effect for longer depending on the dose, treated muscle mass, and individual metabolism.[1][4] When practitioners ask whether Azzalure® is a good Botox alternative, the more useful consideration is often the predictability of the response rather than the maximum degree of correction. Systematic-review evidence supports its efficacy and tolerability for glabellar lines,[1] helping explain why Azzalure® remains a widely used option in aesthetic practice across the UK and Europe.

Azzalure® Compared to Other BTX-A Brands

Azzalure® vs XEOMIN®

XEOMIN® and BOCOUTURE® are both incobotulinumtoxinA products made by Merz, but they are sold under different names depending on the market. XEOMIN® is FDA-approved and has a wider international presence, while BOCOUTURE® is the aesthetic version used in the UK and EU.

Compared with Azzalure®, the main differences lie in formulation and dosing. XEOMIN® units are generally treated as equivalent to BOTOX® units on a 1:1 basis, whereas Azzalure® uses Speywood units. The products also differ in their complexing protein profiles. Storage is another practical consideration: XEOMIN® can be kept at room temperature, while Azzalure® must be refrigerated.[2] This can affect how clinics manage stock and cold-chain requirements. Since no randomized head-to-head trial has directly compared the two, conclusions about their relative efficacy rely on findings from separate studies.

Azzalure® vs BOCOUTURE®

Both products are authorized for aesthetic use in the UK and EU, including the treatment of glabellar lines, but their formulations and dosing systems differ. BOCOUTURE® contains incobotulinumtoxinA without complexing proteins, which is why it is sometimes informally described as a “naked” toxin. This has prompted interest in whether it may carry a lower risk of antibody formation with repeated long-term treatment, although the clinical significance of that difference remains uncertain.

Azzalure® contains abobotulinumtoxinA and uses the Speywood unit system. Merz data describe BOCOUTURE® units as comparable on a 1:1 basis with BOTOX® units, but that relationship should not be applied to Azzalure® dosing. BOCOUTURE® may also offer greater storage flexibility because unopened vials can be kept at room temperature under the conditions specified in the product information. Both products are available by prescription only.

Azzalure® vs BOTOX®

Azzalure® is abobotulinumtoxinA; BOTOX® from AbbVie is onabotulinumtoxinA, and the units are not interchangeable. The generally cited conversion is around 2.5 to 3 Azzalure®/DYSPORT® units for every 1 BOTOX® unit in glabellar treatment, drawn from published consensus guidance, though the exact figure is still argued over in the literature.

Regulatory reach differs substantially. Azzalure® holds an EU/UK marketing authorization for aesthetic use only [2], while BOTOX® holds both FDA approval and European authorization across a much wider indication set that includes therapeutic uses. On onset, some clinical reports place abobotulinumtoxinA slightly ahead at 2 to 5 days against BOTOX® at 3 to 7 days, though this is not a consistent finding across studies [1]. BOTOX® holds the longest published clinical record of any product in the class, which for some clinics is the deciding factor on its own. Clinics running both will find the BOTOX® page useful for cross-referencing indication scope.

Azzalure® vs DYSPORT®

This is a close comparison because Azzalure® and DYSPORT® contain the same active substance, abobotulinumtoxinA, and are made by the same manufacturer.[3] The main difference is their licensing. DYSPORT® is FDA-approved and available in several markets, while Azzalure® is licensed in the UK and EU specifically for aesthetic treatment of glabellar and lateral canthal lines.[2] Both use Speywood units, so Azzalure® 125U is broadly equivalent to DYSPORT® 125U without the need for dose conversion.

Azzalure® vs NABOTA®

Azzalure® and NABOTA® differ in active substance, manufacturer, and regulatory background. Azzalure® is abobotulinumtoxinA from Galderma/Ipsen in France. NABOTA® is prabotulinumtoxinA from Daewoong in South Korea. NABOTA® received FDA approval as Jeuveau®, marketed by Evolus, in 2019 for glabellar lines, while Azzalure® is not FDA-approved, though it carries a longer clinical track record in the EU and UK.

Dosing systems separate them as well. NABOTA® is broadly positioned at 1:1 with BOTOX®, whereas Azzalure® requires approximately 2.5 to 3 units per 1 BOTOX® unit. Both require refrigerated storage, and both are authorized in overlapping European markets. In practice, the choice comes down to regulatory preference, familiarity with the unit system, and pricing.

How to Reconstitute Azzalure®

Reconstitution converts the lyophilized powder into an injectable solution. The process is standard for the class, but the dilution decision carries through to every dose drawn from that vial [2].

• Standard concentration: add 1.25 mL of sterile saline to the 125-unit vial to give 10 units per 0.1 mL [2].
• Alternative concentration:5 mL of saline instead, yielding 5U per 0.1 mL [2].

Once the saline is in, rotate the vial gently rather than shaking it, since shaking can damage the protein structure and affect potency. The result should be clear and colorless. Cloudiness or visible particulate matter means the vial should not be used [5].

Reconstituted product should be used within 24 hours and kept refrigerated until then [2][5]. As for injection technique, Azzalure® is injected into the skin overlying the targeted muscle in small volumes distributed across the treatment area. Technique varies by product and by treatment area, and practitioners should work from the current SmPC and IFU for Azzalure® specifically rather than transferring a protocol from another BTX-A brand.

Storage and Cold-Chain Requirements

Storage conditions are important not only for maintaining potency throughout the shelf life, but also for determining what shipping, receiving, and in-practice handling need to look like. Because trade summaries do not always reflect the approved label accurately, the product information should remain the primary reference.

• Unopened vials: Must be refrigerated at 2°C to 8°C.[2][5] This is the standard storage requirement. Any permitted temperature excursion to 25°C is limited to the specific duration and conditions stated in the label and should not be treated as routine room-temperature storage.
• Reconstituted product: The product should remain refrigerated and be used within 24 hours.[2][5]
• Cold-chain handling: On arrival, practices should check the condition of the packaging and confirm that the shipment remained within the required temperature range, since significant excursions may affect product stability.

Side Effects and Safety

Most adverse reactions reported with Azzalure® are mild and temporary [1][5]:

• Bruising at the injection site
• Headache
• Localized swelling

Ptosis is one of the more important complications to consider, particularly when treating the upper face.[5] Brow asymmetry or small skin depressions may also occur, often in relation to dose, injection depth, or placement rather than the formulation itself. As with other botulinum toxin type A products, unintended spread beyond the treatment area is a recognized class-wide risk.[5]

Azzalure® is contraindicated in patients with known hypersensitivity to botulinum toxin type A and may be unsuitable for those with certain neuromuscular disorders or during pregnancy, in line with the approved product information.[2]

Clinical Benefits of Azzalure®

Holding both glabellar and lateral canthal lines (crow’s feet) on-label means a practitioner treating the two most commonly requested upper-face areas is working within the authorization rather than documenting off-label use for one of them [2].

Some clinicians also report a broader, more even spread in selected areas such as the forehead when injection technique is adjusted for it, which for certain fine lines and wrinkles is the desired behavior rather than a drawback.

Azzalure® Price

Azzalure® sits in the mid-to-premium band of BTX-A pricing, consistent with the Galderma portfolio generally. When running cost comparisons, the useful figure is cost per treatment rather than cost per vial.

Clinics running high glabellar and crow’s feet volume tend to find the per-treatment economics work in Azzalure®’s favor, while practices spreading across multiple off-label areas often weigh it against products with a wider licensed indication set. Practices that buy Azzalure® wholesale on a standing basis should factor in how much of a pack is realistically used within the 24-hour reconstitution window, since unused reconstituted product is a cost that per-vial pricing hides.

Anyone deciding to purchase Azzalure® should also account for both licensed areas, since pricing the glabellar indication in isolation understates what a single 125-unit vial covers in practice.

Where to Buy Azzalure® Wholesale and What to Verify First

Azzalure® is available by prescription only and is supplied through authorized channels to licensed practitioners rather than sold on the open market.[2] Because the rules vary by jurisdiction, professionals who purchase Azzalure® online should check what is permitted in their region before contacting a supplier.

What separates a reliable source from an unreliable one comes down to a handful of checks. Practitioners who buy Azzalure® wholesale should confirm cold-chain handling, LOT number traceability, and documentation practices before accepting delivery, since a refrigerated biologic that has been mishandled in transit gives no visible sign of it. Shipping arrangements deserve the same scrutiny, because a supplier who cannot describe how the cold chain is maintained in transit is not one to accept a delivery from. By the time a potency problem shows up, it shows up in a patient.

The stakes scale with volume. A shipping failure on a bulk consignment takes a larger share of inventory with it than a single mishandled pack would. If you want to buy Azzalure® online, Medical Spa Rx representatives can help. Get in touch for guidance on availability and ordering, whether the requirement is recurring clinic volume or a smaller single order.

Frequently Asked Questions

What is Azzalure®?

Azzalure® is an abobotulinumtoxinA injectable from Galderma/Ipsen, authorized as a prescription-only medicine in the EU and UK [3]. It is approved for moderate to severe glabellar lines and lateral canthal lines in adults under 65, and supplied as 125 Speywood unit lyophilized vials, typically in a 2-vial pack [2].

Is Azzalure® the same as DYSPORT®?

Azzalure® and DYSPORT® contain the same active substance and are made by the same manufacturer, but they are authorized as separate products.[3] DYSPORT® is FDA-approved and marketed in several countries for a broader range of indications. Azzalure® is approved for aesthetic use in the UK and EU, including treatment of glabellar and lateral canthal lines.[2]

What is Azzalure® used for?

Azzalure® is approved for the treatment of moderate to severe glabellar lines and crow’s feet visible when smiling in adults under 65.[2] In practice, clinicians may also use it off label in areas such as the forehead, brows, lips, and neck. Treatment of severe underarm sweating is more commonly linked to DYSPORT® in many markets, so practitioners should check the locally approved indications before using Azzalure® for this purpose.

How is Azzalure® reconstituted?

Add 1.25 mL of sterile 0.9% saline to the 125-unit vial for the standard 10 U per 0.1 mL concentration, or 2.5 mL for 5 U per 0.1 mL [2]. Rotate the vial gently rather than shaking it, then refrigerate and use within 24 hours [2][5].

How long does Azzalure® take to work?

Initial effects are usually noticeable within two to five days, with the full result developing over approximately 10 to 14 days.[1][4] Some clinicians report a slightly faster onset than with other botulinum toxin type A products, although randomized trials have not established this consistently.

How long does Azzalure® last?

Most patients see 3 to 4 months [1]. Dose, muscle mass, and metabolism all shift the figure at the individual level, and treatment area plays a part as well.

How long can Azzalure® be out of the fridge?

Azzalure® must be stored in a refrigerator at 2°C to 8°C, and it should not be treated as a product suitable for routine room-temperature storage.[2][5] The current SmPC permits only a limited single excursion to 25°C under specified conditions. Once reconstituted, the product should remain refrigerated and be used within 24 hours.

Where can practitioners find information on buying Azzalure®?

Medical Spa Rx representatives can advise licensed practitioners on availability, ordering requirements, and what documentation to have ready before an order proceeds. Whether you order Azzalure® online in single packs or order Azzalure® wholesale for a clinic, the process depends on jurisdiction and on the credentials you can produce.

The page and all of its displayed contents are for medical professionals, designed to inform only, and not as a replacement for medical advice.

References

[1] Han X, Bai J, Kuang J. Efficacy and Safety of AbobotulinumtoxinA for Treatment of Moderate-to-Severe Glabellar Lines: A Meta-Analysis. Ophthalmic Plast Reconstr Surg. 2024;40(2):126-133. doi:10.1097/IOP.0000000000002491

[2] Azzalure, 125 Speywood units, powder for solution for injection. Summary of Product Characteristics (SmPC). Medicines.org.uk. Updated February 12, 2026. https://www.medicines.org.uk/emc/product/6584/smpc

[3] Galderma. Azzalure. Available from: https://www.galderma.com/azzalure

[4] Dressler D, Saberi FA, Barbosa ER. Botulinum toxin: mechanisms of action. Arq Neuropsiquiatr. 2005;63(1):180-185. doi:10.1590/s0004-282×2005000100035

[5] Azzalure, 125 Speywood units, powder for solution for injection. Summary of Product Characteristics (SmPC). Medicines.org.uk. Updated February 12, 2026. https://www.medicines.org.uk/emc/product/6584/pil